#denali-therapeutics
Latest news and interesting information about denali-therapeutics.
Denali stock drops after Parkinson drug fails trial
Denali Therapeutics stock falls after Parkinson's drug BIIB122 fails Phase 2b trial. Shares drop 2.9% premarket.
...
